Blueprint for the development of remyelination medicines for multiple sclerosis

Jin Nakahara

doi:10.5692/clinicalneurol.50.870

Blueprint for the development of remyelination medicines for multiple sclerosis

Department of Internal Medicine (Neurology)

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	870
Number of pages	1
Journal	Clinical Neurology
Volume	50
Issue number	11
DOIs	https://doi.org/10.5692/clinicalneurol.50.870
Publication status	Published - 2010

Keywords

Multiple sclerosis
Oligodendrocyte
Oligodendrocyte precursor cell
Remyelination

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.5692/clinicalneurol.50.870

Cite this

@article{af6eeb467f9f4ea7ae875be86081f4ee,

title = "Blueprint for the development of remyelination medicines for multiple sclerosis",

keywords = "Multiple sclerosis, Oligodendrocyte, Oligodendrocyte precursor cell, Remyelination",

author = "Jin Nakahara",

year = "2010",

doi = "10.5692/clinicalneurol.50.870",

language = "English",

volume = "50",

pages = "870",

journal = "Clinical Neurology",

issn = "0009-918X",

publisher = "Societas Neurologica Japonica",

number = "11",

}

TY - JOUR

T1 - Blueprint for the development of remyelination medicines for multiple sclerosis

AU - Nakahara, Jin

PY - 2010

Y1 - 2010

KW - Multiple sclerosis

KW - Oligodendrocyte

KW - Oligodendrocyte precursor cell

KW - Remyelination

UR - http://www.scopus.com/inward/record.url?scp=84856392081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856392081&partnerID=8YFLogxK

U2 - 10.5692/clinicalneurol.50.870

DO - 10.5692/clinicalneurol.50.870

M3 - Article

C2 - 21921480

AN - SCOPUS:84856392081

SN - 0009-918X

VL - 50

SP - 870

JO - Clinical Neurology

JF - Clinical Neurology

IS - 11

ER -

Blueprint for the development of remyelination medicines for multiple sclerosis

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this